Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group Has $1.22 Million Position in The Clorox Company (NYSE:CLX)

Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group lowered its stake in The Clorox Company (NYSE:CLX) by 24.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 7,503 shares of the company’s stock after selling 2,459 shares during the period. Clorox accounts for 0.7% of Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group’s portfolio, making the stock its 27th largest position. Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group’s holdings in Clorox were worth $1,219,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. State Street Corp increased its holdings in shares of Clorox by 3.1% in the third quarter. State Street Corp now owns 8,182,109 shares of the company’s stock valued at $1,332,947,000 after purchasing an additional 245,525 shares in the last quarter. Mizuho Securities USA LLC grew its holdings in Clorox by 46,877.8% during the 3rd quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company’s stock worth $733,095,000 after acquiring an additional 4,490,421 shares during the period. Geode Capital Management LLC grew its holdings in Clorox by 1.1% during the 3rd quarter. Geode Capital Management LLC now owns 3,028,333 shares of the company’s stock worth $491,713,000 after acquiring an additional 33,970 shares during the period. Stifel Financial Corp grew its holdings in Clorox by 1.7% during the 3rd quarter. Stifel Financial Corp now owns 2,334,826 shares of the company’s stock worth $380,370,000 after acquiring an additional 37,967 shares during the period. Finally, Amundi grew its holdings in Clorox by 42.6% during the 4th quarter. Amundi now owns 1,032,283 shares of the company’s stock worth $165,816,000 after acquiring an additional 308,234 shares during the period. Institutional investors and hedge funds own 78.53% of the company’s stock.

Analyst Ratings Changes

A number of analysts have commented on the stock. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $150.00 target price on shares of Clorox in a report on Thursday, January 30th. Barclays lifted their target price on shares of Clorox from $130.00 to $140.00 and gave the stock an “underweight” rating in a report on Wednesday, February 5th. Evercore ISI lifted their target price on shares of Clorox from $145.00 to $155.00 in a report on Tuesday, February 4th. JPMorgan Chase & Co. lifted their target price on shares of Clorox from $171.00 to $173.00 and gave the stock a “neutral” rating in a report on Tuesday, February 4th. Finally, StockNews.com lowered shares of Clorox from a “buy” rating to a “hold” rating in a report on Sunday, January 5th. Three equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat, Clorox presently has a consensus rating of “Hold” and an average target price of $159.62.

Clorox Trading Down 0.7 %

CLX opened at $147.43 on Thursday. The stock has a market capitalization of $18.16 billion, a P/E ratio of 40.28, a P/E/G ratio of 2.62 and a beta of 0.45. The Clorox Company has a 12 month low of $127.60 and a 12 month high of $171.37. The firm’s fifty day simple moving average is $154.81 and its 200 day simple moving average is $160.32. The company has a current ratio of 0.94, a quick ratio of 0.60 and a debt-to-equity ratio of 20.52.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Monday, February 3rd. The company reported $1.55 EPS for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same period in the previous year, the company posted $2.16 EPS. As a group, research analysts anticipate that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 9th. Investors of record on Wednesday, April 23rd will be given a $1.22 dividend. The ex-dividend date is Wednesday, April 23rd. This represents a $4.88 annualized dividend and a yield of 3.31%. Clorox’s dividend payout ratio is currently 133.33%.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.